Table 3.
ANCOVA results for FD symptoms with regard to improvements with STW 5-II versus placebo after 28 days
GIS item | MD (95% CI) | p value |
---|---|---|
Epigastric pain | 0.39 (0.32–0.55) | <0.0001* |
Fullness | 0.38 (0.20–0.56) | <0.0001* |
Early satiety | 0.36 (0.17–0.55) | 0.0002* |
Nausea | 0.28 (0.08–0.47) | 0.0071* |
Vomiting | 0.06 (−0.25 to 0.37) | 0.6950 |
Abdominal cramps | 0.32 (0.14–0.50) | 0.0005* |
Acid eructation/heartburn | 0.45 (0.25–0.65) | <0.0001* |
Sickness | 0.27 (0.08–0.46) | 0.0052* |
Loss of appetite | 0.33 (0.13–0.54) | 0.0018* |
Retrosternal discomfort | 0.52 (0.32–0.71) | <0.0001* |
Sum score | 2.44 (1.57–3.3) | <0.0001* |
CI, confidence interval; GIS, gastrointestinal symptom.